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a  b  s  t  r  a  c  t
High  cardiovascular  mortality  is  well  documented  in  lean phenotypes  exhibiting  visceral  fat  accumu-
lation.  In  contrast,  corpulent  phenotypes  with  predominantly  subcutaneous  fat  accumulation  display  a
surprisingly  low  mortality.  The  term  ‘obesity  paradox’  reﬂects  the  difﬁculty  in  understanding  the  bio-
logical  mechanisms  underlying  these  clinical  observations.  The  allostatic  load  model  of  chronic  stress
focuses  on  glucocorticoid  dysregulation  as  part  of  a ‘network  of  allostasis’  involving  autonomic,  endocrine,
metabolic, and  immune  mediators.  Here,  we  expand  upon  the energetic  demands  of the  brain  and  show
that  ‘habituators’  and  ‘non-habituators’  develop  divergent  patterns  of  fat  distribution.  Central  to this
process  is  the  recurrent  rise  in the  cerebral  energy  need  (arousal)  that non-habituators  experience  dur-
ing  chronic  stress.  These  neuroenergetic  alterations  promote  visceral  fat  accumulation,  subcutaneous  fat
loss, and atherogenesis  with  subsequent  cardiovascular  events.  Habituators  are  more  or  less  protected
against  such  cardiovascular  complications,  but  there  is a metabolic  trade-off  that we  shall  discuss  in  the
present  paper.
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. Introduction
Ten years ago, the American nephrologist Kamyar Kalantar-
adeh called attention to a series of surprising observations
Kalantar-Zadeh and Kopple, 2006). In patients with chronic kid-
ey disease undergoing maintenance hemodialysis a high body
ass was incrementally associated with better survival (Kalantar-
adeh et al., 2005; Kopple et al., 1999). These counterintuitive
ndings prompted a long-lasting debate labeled the ‘obesity para-
ox’. In line with these reports, better survival rates have also
een documented in obese patients who had suffered from stroke,
ntracerebral hemorrhage, myocardial infarction, heart failure, sep-
is or type-2-diabetes when they were compared with those of
ean patients with the same disease (Garrouste-Orgeas et al., 2004;
uettner et al., 2007; Hallin et al., 2007; Fitzgibbons et al., 2009; Kim
t al., 2011; Vemmos et al., 2011; Carnethon et al., 2012). Note-
orthy, the earlier studies did make use of one anthropometric
easure only: the body mass index (BMI).
In the 1980s, the Swedish endocrinologist Per Björntorp empha-
ized the role of visceral fat (Björntorp, 2001). First, he found that
isceral fat mass was associated with hypercortisolemic states
Rebuffe-Scrive et al., 1988). Björntorp liked to recount his prob-
ems in publishing data that clearly demonstrated that women
isplaying visceral fat accumulation were more likely to carry psy-
hosocial burdens. They were more often unemployed, had gone
hrough a divorce, had spent time in prison, or had ﬁnancial prob-
ems. For Björntorp this was a clinical and socioeconomic way  to
escribe stress eventually leading to the accumulation of visceral
at. Initially nobody was willing to publish these data, because they
eemed too unlikely. However, Per Björntorp systematically built
p a plausible sequence proposing that chronic stress, affecting
he hypothalamus–pituitary–adrenal (HPA) axis, would eventually
ead to visceral fat accumulation. Second, Björntorp was among the
rst investigators who reported that visceral fat accumulation was
ssociated with a high cardiovascular mortality risk (Larsson et al.,
984).
Per Björntorp‘s ﬁndings add an important aspect to the ‘obe-
ity paradox’ debate. The earlier studies – lacking data on visceral
at – showed the often-mentioned U-shaped BMI-mortality curves
Whitlock et al., 2009). In contrast, recent epidemiological stud-
es made combined use of two anthropometric measures: waist
ircumference (as an estimate of visceral fat) and the BMI  (as
n estimate of subcutaneous fat). By using mutual statistical
djustment for both of these measures, several large population-
ased cohort studies from the United States, the United Kingdom,
enmark, Norway, and Mauritius could show a more differentiated
icture (Cameron et al., 2012; Berentzen et al., 2010; Petursson
t al., 2011; Krakauer and Krakauer, 2012, 2014): First, they
howed no U-shaped mortality curves. Second, each of these stud-
es conﬁrmed what Björntorp had described as the risk effects of
aist circumference on mortality, and also what Kalantar-Zadeh
ad reported as the protective effects of high BMI on mortality.
n line with these ﬁndings, the Whitehall Study and the Aer-
bics Center Longitudinal Study (ACLS) provided evidence that
ean subjects who displayed high waist circumference (or another
etabolic abnormality) had the highest mortality risk, while sub-
ects with a high body mass who lacked high waist circumference
or other metabolic abnormalities) had the lowest mortality risk
Hamer and Stamatakis, 2012; Ortega et al., 2013). In all, there is .  . .  . . . .  . . .  . . . . .  .  . . . . .  . .  .  .  . . .  . . .  . . . . . . .  .  . . .  .  . . . .  .  .  . . . . .  . . . . . . .  .  .  .  . . .  .  . .  . . . .  .  147
mounting evidence that waist circumference and BMI  indicate
divergent mortality risks.
Unfortunately, the obesity-paradox debate refers almost exclu-
sively to correlational studies, and the only existing randomized
controlled trail in the ﬁeld does not even support a direct causal
relationship between body mass and mortality (Look AHEAD
Research Group, 2013). Nevertheless, the opponents in this debate
do more and more agree upon ‘body shape’ as being essential for
assessing the cardiovascular mortality risk in general populations:
Visceral fat appears to identify the high risk phenotype, while sub-
cutaneous fat doesn’t. Although the clinical picture has become
much clearer today (Peters and McEwen, 2012), it remains still
poorly understood what biological mechanisms underlie the ‘obe-
sity paradox’ phenomenon. Here we look at its pathophysiology
from a neuroendocrine and neuroenergetic perspective and bring
together concepts and lines of investigation that highlight the role
of toxic stress and the inability to handle daily stressors as funda-
mental determinants.
2. Allostatic load
In the 21st century, a number of randomized controlled trials
concerning chronic stress provided causal evidence for Björntorp’s
originals ideas. First, chronic psychosocial stress has been shown
to increase visceral fat mass in non-human primates (Kaufman
et al., 2007). Second, cognitive-behavioral and resource-activating
stress management programs have been shown to reduce corti-
sol stress responses during a standardized psychosocial challenge
(Storch et al., 2007; Hammerfald et al., 2006; Gaab et al., 2003).
‘Stress reduction’ programs in turn have been shown to improve
cardiovascular survival (Orth-Gomer et al., 2009; Gulliksson et al.,
2011). In detail, two  large-scale trials from Sweden have studied
patients who had suffered from their ﬁrst myocardial infarction.
The stress reduction program consisted of ﬁve key components
with speciﬁc goals – education, self-monitoring, skills training, cog-
nitive restructuring and spiritual development – and was focused
on stress management, coping with stress, and reducing experience
of daily stress, time urgency, and hostility. Both studies showed that
those in the intervention group had a lower rate of second or third
myocardial infarction and a lower rate of cardiovascular mortal-
ity as compared to the control group. Thus, chronic psychosocial
stress – as Björntorp has predicted – can cause both visceral fat
accumulation and cardiovascular death.
Here we refer to the conceptual frameworks of ‘allostasis and
allostatic load’ (McEwen and Stellar, 1993) and the ‘Selﬁsh Brain’
theory (Peters et al., 2004) to address the question how genetic
endowments and life experience interact to differentially affect vis-
ceral fat, subcutaneous fat, and mortality. According to the concept
of ‘allostasis’, allostatic regulation occurs when a subject is exposed
to a changing environment and engages in behaviors and physio-
logical responses that promote adaptation and increased chances
for survival, at least in the short run. As part of allostatic regulation
the brain is supplied with extra energy, which in turn can be used
to cover the increased brain energy needs arising from enhanced
cerebral functioning (e.g. increased vigilance, updating the proba-
bility distributions of expected outcomes). Yet, the metabolic and
regulatory events occurring during an acute challenge differ from
those occurring under chronic inhospitable conditions. According
to the concept of ‘allostatic load’ the mediators of neuroendocrine,
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utonomic, metabolic and immune systems become chronically
ctivated so that turbulent blood ﬂow, hypertension, macrophage
issue inﬁltration, oxidative stress, atherosclerosis, impaired mem-
ry and deteriorated mood accelerate disease progression. All the
ong-term effects of chronically activated stress responses – which
ead to the wear and tear of the organism – are referred to as
llostatic load (McEwen, 1998). Once, serious pathophysiology has
ccurred the effects are denoted as ‘allostatic overload’ (McEwen
nd Wingﬁeld, 2003).
In the current paper, we deﬁne ‘stress’ as a ‘state of increased
erebral energy need’ that occurs when a person is uncertain of
ow to safeguard his/her future physical, mental and social well-
eing. Such a state of increased individual uncertainty can lead
o three results: ﬁrst, ‘good’ stress processes indicate a satisfy-
ng result, in which certainty can be regained and the individual
xperiences a sense of mastery and good self-esteem (McEwen and
ianaros, 2010). Second, tolerable stress processes indicate a result,
n which the uncertainty could not be resolved but nevertheless
he individual may  stabilize through buffering mechanisms such
s habituation, coping strategies or supportive relationships. Third,
toxic stress’ processes indicate the result in which the buffering
echanisms fail, and the individual is at high risk for physical and
ental morbidity and excess cardiovascular mortality (McEwen,
012).
. Brain energy ‘supply and demand’
So far, the ﬁeld of neuroenergetics has received little attention
mong the obesity paradox disputants. The Selﬁsh Brain theory –
ounded in 1998 by one of the authors (A. P.) – integrated cerebral
nd peripheral energy metabolism (Peters et al., 2004). Its central
dea is that the brain occupies a special hierarchical position in
he human organism. The theory was based on experimental evi-
ence from more than 12,000 publications. Among other things, the
ist of evaluated publications included the groundbreaking work
f Luc Pellerin and Pierre Magistretti on the ‘astrocyte-neuron-
nergy-on-demand’ principle (Pellerin and Magistretti, 1994). Key
o the Selﬁsh Brain theory is the brain-pull hypothesis (Peters and
angemann, 2009). ‘Brain-pull’ is referred to as the force with which
he brain actively demands energy from the body. It contrasts with
he conventional nutritionist’s and obesity-expert’s view (the null
ypothesis), which states that the brain is supplied in a passive
anner, e.g. by diffusion or passive transport driven by a concen-
ration gradient. According to the conventional view no brain-pull
unction is required. The brain-pull hypothesis, however, stated
hat the brain is supplied in an active manner with the help of
peciﬁc brain-pull mechanisms.
After the Selﬁsh Brain theory has been explicated in 2004,
nexpected evidence emerged. Published in 1921, then missing
or almost a century before surfacing in 2007, the work of Marie
rieger provided a unique opportunity for comparing the two
bove-mentioned competing hypotheses (Krieger, 1921). Just prior
o the appearance of Krieger’s data, logistic-supply-chain analyses
ave been made that predicted opposing metabolic outcomes in
he scenario of food deprivation (Peters and Langemann, 2009): If
he conventional view (null hypothesis) were true, substantial mass
oss was predicted to occur in both body and brain. If the brain-pull
ypothesis were true, mass loss was predicted to occur only in the
ody—but not in the brain.
In fact, Krieger had reported that in the state of inanition all
rgans like the heart, liver and kidney lost approximately 40%
f their mass, whereas the brain mass hardly changed (less than
%) (Krieger, 1921). Thus, updating the probabilities of the com-
eting hypothesis with the help of Krieger’s data gave a huge
oost to the brain-pull hypothesis. Adding further evidence frombehavioral Reviews 56 (2015) 139–150 141
experiments using state-of-the-art technology, including magnet
resonance imaging and spectroscopy (Peters et al., 2011; Kubera
et al., 2013; Oltmanns et al., 2008; Goodman et al., 1984; Muhlau
et al., 2007) and positron-emission-tomography (Kuzawa et al.,
2014), more and more increased the likelihood of the brain-pull
hypothesis being true.
Now, that the conventional view advocating the null hypothe-
sis has become increasingly unlikely, it seems promising to look at
the ‘obesity paradox’ observations in the light of brain-pull mech-
anisms. Acute stress belongs to the conditions when the brain
enters a hypervigilant state; the additional cerebral energy needs
arising from this transition are covered by brain-pull mechanisms
(Hitze et al., 2010; Madsen et al., 1995; Kubera et al., 2012). One
of these mechanisms is called ‘cerebral insulin suppression’. Cere-
bral activation of the sympathetic-nervous system (SNS) and the
HPA axis vigorously suppresses insulin secretion from pancreatic
 cells (Hitze et al., 2010; Ahren, 2000; Billaudel and Sutter, 1982;
Woods and Porte, 1974). Concomitant lowering of the vagal tone
also contributes to the suppression of insulin secretion (Woods
and Porte, 1974). As a consequence, the insulin-dependent glu-
cose uptake via glucose transporter GLUT4 into the body periphery
(muscle, subcutaneous and visceral fat) becomes limited. At this
point, glucose is available via insulin-independent GLUT1 transport
across the blood brain barrier (Hasselbalch et al., 1999; Seaquist
et al., 2001). Important Conclusion: GLUT1 glucose uptake safe-
guards basal energy supply of vital organs, like brain and immune cells
(Deng et al., 2014), while GLUT4 allows the storage of surplus energy
in muscle and fat cells (Shepherd and Kahn, 1999). Thus, ‘cerebral
insulin suppression’ allocates energy to the brain in order to maintain
cerebral energy concentrations.
Chronic stress belongs to the conditions when repeated rises
in cerebral need (arousal) and brain-pull activity occur, inhibi-
ting peripheral GLUT4-mediated glucose uptake in the long run,
thereby promoting the loss of subcutaneous adipose tissue. In vis-
ceral fat, however, chronic stress exerts opposite effects. This is so
because visceral adipocytes are particularly sensitive to glucocor-
ticoids (Lee et al., 2014). Here, chronic stress leads to an increase in
adipocyte GLUT1-gene expression (Zini et al., 2009) and a decrease
in adipocyte GLUT4-gene expression (Waller et al., 2011; Lefebvre
et al., 1998). These changes in transporter proﬁles are triggered
by chronic activation of SNS and the HPA-axis (Kuo et al., 2007).
Thereupon, macrophages invade into the visceral fat tissue where
they release tumor necrosis factor (TNF). TNF in turn alters the
gene expression of the respective glucose transporters (Lumeng
et al., 2007; Cornelius et al., 1990; Battelino et al., 1999). Enhanced
GLUT1-mediated glucose uptake into abdominal adipocytes favors
visceral fat accumulation (Lundgren et al., 2004). In all, repeated
activation of brain-pull mechanisms during chronic stress leads to
loss of subcutaneous fat – but to accumulation of visceral fat.
Epel et al. (2000) brought Björntorp’s ﬁrst idea “chronic
stress makes visceral fat grow” a decisive step further. When
the researchers studied lean people with visceral fat accumula-
tion and compared them with those showing other body shapes,
they made a spectacular discovery. This was precisely the kind
of phenotype that was  ‘non-habituator’. Thus, non-habituators,
but not habituators, react to chronic stress by developing the
above-described ‘lean-but-wide-waisted’ phenotype. ‘Stress habit-
uation’ is an essential form of plasticity that reduces glucocorticoid
mobilization in response to stressors that have been previously
experienced, but not to novel stressors (Fig. 1). In this way, habit-
uation avoids needless glucocorticoid secretion but maintains the
ability to mount a hormonal response. The metabolic consequences
of chronic stress in habituators are completely different from those
seen in non-habituators. These consequences essentially concern
the ‘body-pull’ (Box 1), i.e. appetite and ingestive behavior, and
will be discussed further below.
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Fig. 1. Differential modiﬁcations of stress reactivity. We deﬁne ‘habituators’ as those
who  show repetition-induced response attenuation (neuroendocrine, cardiovascu-
lar, neuroenergetic, and emotional), when being chronically exposed to an unsafe
environment. Over time, they develop a low ‘stress reactivity’. In contrast, we deﬁne
‘non-habituators’ as those who  do not show such a modiﬁcation of responses.
They uphold their high stress reactivity, when continuously being exposed to an
unsafe environment. With repeated experimental stress challenges (TSST), subjects
have been shown to either habituate or not habituate in their cortisol response
(Kirschbaum et al., 1995).
Box 1: Glossary
Allostasis The process whereby an organism maintains
physiological stability (homeostasis) through chang-
ing parameters of its internal milieu by matching
them appropriately to the environment.
Allostatic load The biological ‘wear and tear’ that allo-
static mechanisms exert on organs and tissues under
chronic stress that cumulatively predisposes to the
development of disease.
Allostatic overload An extreme form of allostatic load in
which dysregulation of allostatic responses, often in
response to chronic stressors, lead to disease. Both
allostatic load and allostatic overload occur in nature.
Selﬁsh Brain theory Conceptual framework that describes
the characteristic of the brain to cover its own energy
requirements with the highest priority. In the compe-
tition between organs, the brain appears to behave
in a ‘selﬁsh’ manner. The theory has been founded
and formulated mathematically between 1998 and
2004. Meanwhile, interdisciplinary work has pro-
vided experimental evidence for the validity of its
axioms.
Brain-pull The force with which the brain actively demands
energy from the body. The most important brain-pull
mechanism is referred to as ‘cerebral insulin suppres-
sion’.
Cerebral insulin suppression A fall in amygdala or
hypothalamic neuronal adenosine triphosphate
(ATP) concentrations stimulates the sympathetic
nervous system and the hypothalamus–pituitary–
adrenal axis. Both systems suppress insulin secre-
tion from the pancreatic  cells, and in so doing limit
the insulin-dependent glucose uptake into the body
periphery (muscle, fat tissue). As a consequence,
glucose is available via the insulin-independent
transport across the blood-brain barrier.
Body-pull The force with which the body actively demands
energy from the environment. Appetite and total
energy intake depend on the energy status of the
blood (glucose), the brain (ATP) and the body (indi-
cated by leptin, ghrelin, etc.).behavioral Reviews 56 (2015) 139–150
4. Non-habituators’ trade-offs
4.1. Hypervigilance
Once the environment changes and becomes unsafe, individ-
uals may  ﬁnd themselves confronted with the question: “Can one
of my options safeguard my future physical, mental and social wellbe-
ing?” ‘Stress’ occurs in those individuals who are uncertain about
the answer. During acute stress, the brain enters a hypervigi-
lant state in order to reduce the occurring uncertainty as soon
as possible. To obtain the necessary information, additional cere-
bral energy is required. In principle, getting any information costs
energy (Brillouin, 1953). Redundant brain-pull mechanisms have
been discovered that are able to immediately procure the brain
with such extra energy from the body.
The anterior cingulate cortex (ACC) plays a key role in processing
the subjective estimation as to whether future outcomes are uncer-
tain (Sarinopoulos et al., 2010; Karlsson et al., 2012; Behrens et al.,
2007; Liljeholm et al., 2013; Paulus et al., 2002; Feinstein et al.,
2006). The amygdala, on the other hand, has a key function for
assessing threat to wellbeing (McEwen, 2007). Subjects who feel
uncertain about their future wellbeing typically display interac-
tions between ACC and amygdala (Sarinopoulos et al., 2010). The
ACC-amygdala complex can activate two  descending pathways:
ﬁrst, projections to the locus coeruleus norepinephrine (LC-NE) sys-
tem, (thereby inducing a hypervigilant state (Valentino and Van
Bockstaele, 2008; Reyes et al., 2011), which has been found asso-
ciated with an increased cerebral energy need, Hitze et al., 2010;
Kubera et al., 2012); and second, projections to the ventromedial
hypothalamus and the paraventricular nucleus (thereby activating
the SNS and HPA-axis, which in turn procure the brain with the
extra energy needed) (Hitze et al., 2010; Kubera et al., 2012).
During chronic stress, non-habituators have to ﬁnd a neuroen-
ergetic solution that allows them to activate their energy-costly
hypervigilant state. The three following solutions are feasible
• enhancing cerebral blood ﬂow,
• enhancing cerebral glucose supply and
• enhancing cerebral ketone supply, but these strategies are
afﬂicted with the trade-offs
• high-ﬂow-speed arterial turbulences,
• subcutaneous fat loss and
• visceral fat accumulation, respectively.
4.2. High-ﬂow-speed arterial turbulences
During psychosocial stress, SNS-activation raises cardiac out-
put mainly by accelerating heart rate (Jones et al., 2011). High
cardiac output in turn mounts cerebral energy supply. However,
the increase in blood ﬂow velocity has a trade-off of great con-
sequence: turbulences. Experimentally induced adrenoreceptor
activation increased heart rate, blood ﬂow velocity, and caused tur-
bulences in the arterial system (Falsetti et al., 1983; Hanai et al.,
1991). Since turbulent ﬂow is irregular, it turns out to be highly
uneconomical with respect to energy transport. From a physical
point of view, turbulences greatly increase friction and for the same
discharge a higher blood pressure must be applied than in the lam-
inar case. Therefore it appears of primary importance to maintain
laminar (regular) blood ﬂow in order to fuel the brain in the most
economical manner. The problem is that toxic stress can cause tur-
bulent blood ﬂow that starts a vicious cycle, which can lead to
atherosclerosis.4.2.1. The laminar-turbulent transition
The transition to turbulence in ﬂuid ﬂow is an everyday experi-
ence. As a faucet slowly opens, the initial laminar ﬂow of water
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hanges into an irregular ﬂow. Modern physical experiments
resented in detail how high ﬂow speed increases the risk of tur-
ulences (Hof et al., 2004; Darbyshire and Mullin, 1995).
The transition to turbulent ﬂow also depends on the geometry
f the pipes. In the human vascular system bifurcations, branch-
ng points and the inner aspect of curvatures are predilection sites,
here disruption of laminar ﬂow is often observed (Malek et al.,
999). Areas with reversed ﬂow (i.e., ﬂow separation, recirculation)
r circumferential swirling are characteristic of disturbed laminar
ow. In turbulent ﬂow the velocity at any given point varies contin-
ously over time, even though the overall ﬂow is steady. The outer
dges of vessel bifurcations are particular susceptible areas where
urbulences occur.
.2.2. Adaptive vascular remodeling
The arterial branch of circulation is a biological system dis-
laying a high degree of plasticity (Chatzizisis et al., 2007). If
he vasculature is burdened by increased ﬂow speed, e.g. during
olerable stress, it may  react upon the ﬂow changes by modify-
ng its diameter or its local shape. Remodeling of the local shape
ccurs particularly at the outer edges of blood vessel bifurca-
ions.
The luminal surface of the blood vessel and its endothelial
urface are constantly exposed to hemodynamic shear stress.
ndothelial shear stress is the tangential component of the fric-
ional force exerted in the endothelial layer by the ﬂowing blood.
ndothelial shear stress plays a key role in ﬂow-speed control
nd in wall remodeling (Caro et al., 1971; Kamiya and Togawa,
980; Girerd et al., 1996; Langille and O’Donnell, 1986). Shear
orces are detected by speciﬁc mechanosensors, which are located
n the tight junctions between neighboring endothelial cells and
irectly transmit mechanical force in chemical signaling (Tzima
t al., 2005).
These mechanoreceptors help to either prevent or eliminate tur-
ulences. If the risk of a laminar-turbulent transition rises with
ncreasing ﬂow speed, endothelial shear stress increases at the
ame time; then these mechanoreceptors upturn endothelial nitric
xide synthase (eNOS), thereby increasing the bioavailability of
itric oxide (NO), and in so doing they induce vasodilatation, which
nally slows down ﬂow speed (Kwak et al., 2014; Chatzizisis et al.,
007). In this way, mechanoreceptor-induced regulatory mecha-
isms help to normalize ﬂow speed and minimize the risk of a
aminar-turbulent transition.
If the turbulences are already present, these mechanorecep-
ors detect such ﬂow irregularities (e.g. recirculation) by assessing
ow endothelial shear stress (Kwak et al., 2014; Chatzizisis et al.,
007). Thereupon they promote the uptake of circulating low-
ensity lipoprotein cholesterol (LDL) particles into the endothelial
ells (Chatzizisis et al., 2007). When LDL particles are engulfed
n the endothelial layer they are associated with intimal proteo-
lycans, become entrapped, and undergo oxidative modiﬁcation
Nakashima et al., 2007; Libby, 2002). Oxidation of LDL results in
ecruitment of circulating monocytes, T-lymphocytes, mast cells
nto the intima. These cells sustain dynamic matrix remodeling.
ver time, vascular smooth muscle cells along with ﬁbroblasts cre-
te a ﬁbrous cap around the lipid core.
The ﬁbrous cap along with the lipid core constitutes the so called
ﬁbrous cap atheroma’ (Chatzizisis et al., 2007). Such a ﬁbrous cap
theroma may  mechanically function as a ﬁlling element, a sort of
fat pad’, which can expand into the vessel lumen. The protrusion
ight help to ﬁll out and quiet down the area of turbulent ﬂow.
hus, the ﬁbrous cap atheroma can be regarded as the ﬁnal product
f a regulatory process that aims at reestablishing laminar blood
ow. In all, the arterial branch of circulation is able to adapt to
he burden of tolerable stress by undergoing plastic modiﬁcation,behavioral Reviews 56 (2015) 139–150 143
thereby safeguarding laminar blood ﬂow particularly at susceptible
vessel sites.
4.2.3. Persistent turbulences and atherosclerosis
During toxic stress, recurrent or persistent high cardiac out-
put overstrains the capacity of ‘adaptive vascular remodeling’
to reestablish laminar blood ﬂow. At this point, allostatic load
manifests in an increased risk of turbulences at predilection
sites, thereby causing atheroma progression and complications.
This situation is aggravated by the fact that high sympathetic
activity coincides with low parasympathetic activity. Impaired
parasympathetic activity and lack of ‘vagal brake’ would allow
sympathetic reaction to ordinary events and have greater impact
on blood vessels (Sloan et al., 2007a,b). At the same time,
sympathetic activity increases inﬂammation (Bierhaus et al.,
2003; Djuric et al., 2012), and impaired parasympathetic activ-
ity leads to a lack of anti-inﬂammatory processes (Rosas-Ballina
and Tracey, 2009; Sloan et al., 2007a). In the presence of a
persistently high cardiac output and an unfavorable sympa-
thetic/parasympathetic balance, turbulences will promote either
‘excessive expansive modeling’ or ‘constrictive modeling’ of the
local vascular wall.
With excessive expansive remodeling both vessel and lumen
become actually larger than the neighboring noninvolved areas.
A self-perpetuating pathological interaction is established among
local low endothelial shear stress, excessive expansive remodeling
and plaque inﬂammation transforming the ﬁbrous cap atheroma
into a thin cap ﬁbroatheromas (Koskinas et al., 2010). Thin cap
ﬁbroatheromas have a high risk of plaque rupture, which may  lead
to occlusive thrombosis and subsequent acute coronary syndrome
or stroke.
With constrictive remodeling, persistent low endothelial shear
stress leads to further ﬁbroproliferation, expansion of the atheroma
into the vessel lumen, stenotic plaque development and lumen
narrowing (Stone et al., 2012). As complications of constrictive
remodeling stable angina, arterial ﬁbrillation, or transient ischemic
attacks may  occur. In all, repeated rises in brain energy demand
during chronic stress may  increase the risk of turbulent blood ﬂow,
thereby promoting the progression of atherosclerosis and its com-
plications.
4.2.4. Stress reactivity and cardiovascular mortality
Epidemiological evidence showed that in stress-burdened peo-
ple, stress reactivity was  positively associated with the risk of
atherosclerosis and mortality (Seldenrijk et al., 2012; Hamer et al.,
2010, 2012; Lynch et al., 1998; Everson et al., 1997). Cardiovas-
cular reactivity to acute mental stress has also been shown to be
positively associated with 16-year cardiovascular mortality (Carroll
et al., 2012). When compared to women, men  displayed higher cor-
tisol reactivity to a psychosocial challenge (Kudielka et al., 2009),
experienced different environmental strains (e.g. in relations with
family) (Block et al., 2009), and showed earlier ﬁrst manifestation
of cardiovascular disease (Lloyd-Jones et al., 1999; Leening et al.,
2014). When studying a population of men  and women, the gen-
der gap in cardiovascular disease was found partly explained by
differences in cortisol reactivity and partly by other gender-related
differences (Hamer et al., 2010, 2012), e.g. level of social support
(Weidner, 2000). A neuroimaging study demonstrated that carotid
intima-media thickness was  positively associated with amygdala
reactivity and a higher functional connectivity between the ACC
and the amygdala (Gianaros et al., 2009). Thus, the ‘allostatic over-
load’, which manifests at heart and brain vessels in a detrimental
manner, depends on both the presence of an adverse environment
and the individual’s stress reactivity. In this way, Björntorp’s second
1 nd Biobehavioral Reviews 56 (2015) 139–150
i
a
4
a
c
c
n
s
T
u
w
2
c
n
(
c
t
w
s
s
i
c
a
e
t
4
a
l
h
s
b
s
m
i
t
l
n
g
2
t
f
f
m
a
e
m
b
T
d
t
i
o
l
t
r
d
t
d
Fig. 2. The bifurcation in life history. Different phenotypic traits may  develop when
people live in unsafe environments. If ‘non-habituators’ are exposed to an unsafe
environment, they develop a ‘lean-but-wide-waisted’ phenotype; they display a
high cardiovascular mortality risk. In contrast, ‘habituators’ exposed to an unsafe44 A. Peters, B.S. McEwen / Neuroscience a
dea “chronic stress causes cardiovascular mortality” found consider-
ble support from latest studies.
.3. Subcutaneous fat loss
During psychosocial stress, SNS-activation releases free fatty
cids from subcutaneous fat depots into the venous system, which
oalesces into the two major veins, the superior and inferior vena
ava. From here, free fatty acids are transported into the coro-
ary arteries, where they supply cardiac muscles, and into the
ystemic circulation, where they mainly supply skeletal muscles.
he heart uses free fatty acids as its principle fuel (>70%), but it also
ses glucose as a supplementary fuel, particularly during increased
orkload (via GLUT4) and myocardial ischemia (via GLUT1) (Abel,
004; Young et al., 1999; Brosius et al., 1997). The skeletal mus-
les also use free fatty acids and glucose. The more the energetic
eeds of cardiac and skeletal muscles are covered by free fatty acids
instead by the means of glucose), the more mounts the share of glu-
ose that is available for the brain. During psychosocial challenges,
his here-described brain-pull mechanism operates in combination
ith the above-mentioned brain-pull mechanism ‘cerebral insulin
uppression’. The latter mechanism prevents glucose uptake by
keletal muscle and subcutaneous fat, thereby additionally mount-
ng the share of glucose for the brain. So far, so good—but enhancing
erebral glucose supply has a trade-off. As recurrent brain-pull
ctivations blunt adipocyte energy inﬂux and heighten its energy
fﬂux, they cause long-term losses of subcutaneous fat mass and
hus shape a lean phenotype.
.4. Visceral fat accumulation
During psychosocial stress, SNS-activation releases free fatty
cids from visceral fat depots into the hepatic portal vein. In the
iver, free fatty acids are converted into ketone bodies (e.g. -
ydroxybutyrate). From there, ketones are transported via the
ystemic circulation toward the brain, where they enhance cere-
ral energy supply. In fact, experimentally-induced psychosocial
tress increased concentrations of serum -hydroxybutyrate by
ore than 400% (Kubera et al., 2014).
Frequent demands for free fatty acids from visceral fat may
nduce phenotypic changes, which may  be regarded as a long-
erm adaptation: visceral fat accumulation. Psychosocial stress
eads to the release of neuropeptide Y (NPY) from sympathetic
erves, which in turn up regulates NPY and its receptors in a
lucocorticoid-dependent manner in the visceral fat (Kuo et al.,
007). This NPY response leads to angiogenesis in visceral fat
issue, local macrophage inﬁltration and the proliferation in dif-
erentiation of new adipocytes resulting in an increase in visceral
at mass. As mentioned above, TNF from visceral-fat-resident
acrophages favors basal glucose uptake via GLUT1 into visceral
dipocytes (Lumeng et al., 2007; Cornelius et al., 1990; Battelino
t al., 1999). The shift in adipocyte glucose transporter proﬁle
akes these cells more similar to the endothelial cells at the
lood-brain barrier, which are exclusively equipped with GLUT1.
hus, with chronic stress both the brain and the visceral fat
epot are supplied by basal GLUT1-mediated glucose uptake. Given
hese parallel transport features of brain and visceral fat tissue,
t appears that during chronic stress the visceral fat grows in
rder to supply the brain with extra fuel from an extra-cerebrally
ocated energy depot. Nevertheless, Per Björntorp’s original idea
hat chronic stress leads to visceral fat accumulation has here
eceived convincing experimental support. As we  will see in more
etail below, habituators and non-habituators differ in their fat dis-
ribution patterns: habituators do not develop such large visceral
epots.environment develop a ‘corpulent-but-narrow-waisted’ phenotype; they display a
lower cardiovascular mortality risk. Of course, there are also transitional or mixed
phenotypes.
5. Habituators’ trade-offs
5.1. Blunted hypervigilance
Stress reactivity can be viewed as a trait that may  change dur-
ing the life course. Once exposed to a volatile environment (e.g.
low control at work, unhappy relationship, poverty) people have
been shown to react in two distinct genetically predisposed pat-
terns (Figs. 1 and 2). As non-habituators are characterized by their
maintenance of a high reactivity to recurrent stress episodes, habit-
uators – who  initially responded to stress in a high reactive manner
– reduce their response by time, and from now on exhibit low
neuroendocrine, cardiovascular, neuroenergetic, and emotional
reactivity to stress. Noteworthy, habituation is selective—allowing
better discrimination of what is not versus what may  be threaten-
ing.
Kirschbaum et al. (1995) performed a ‘classical habituation
experiment’ where they repeatedly exposed participants to the
same ‘homotypic’ stressor (Trier Social Stress Test; ‘TSST’). Strikin-
gly, participants showed ‘all-or-none’ reactions: two  third of them
habituated, while one third did not. As habituators become low
reactive to stress, they may  avoid futile hypervigilance, save brain
energy, and thereby prevent high-ﬂow-speed arterial turbulences
(McEwen, 2012). In this way, habituators can reduce their allostatic
load by attenuating their stress responses, despite of being exposed
to an inhospitable environment. However, becoming low reactive
to stress limits one of people’s most vital abilities: being able to
demand sufﬁcient brain energy from the body. When trapped in
an unsafe environment, habituators are faced with the difﬁculty
of having low brain-pull reactivity. Now, their organisms strive to
ﬁnd a neuroenergetic solution that allows them to preserve cere-
bral functioning and cerebral energy concentrations. As we  will see
further below, one solution is feasible for dealing with a limited
brain-pull function, i.e.
• compensatory enhancement of the body-pull (appetite and
ingestive behavior), but this strategy is afﬂicted with a trade-off:
• body mass gain (Peters and Langemann, 2009).Stress habituation is governed by the medial prefrontal cortex
(mPFC) (Hill and Tasker, 2012). If an individual has habituated to a
homotypic stressor, the mPFC disrupts stressor-induced amygdala
A. Peters, B.S. McEwen / Neuroscience and Bio
Fig. 3. Simpliﬁed model integrating molecular mechanisms underlying stress habitu-
ation in the mPFC. DSI denotes ‘Depolarization-induced Suppression of Inhibition’.
A  homotypic stressor stimulates neuron1 to release glutamate, thereby activating
neuron2. If the stimulus is strong enough, neuron2 releases large amounts of endo-
cannabinoids, which in turn – via neuron3 – disinhibit neuron1. In this way, only
strong stimuli can turn the DSI switches into the ON position, thereby reinforcing
neuron1-to-neuron2 transmission. During chronic stress, elevated glucocorticoid
concentrations enhance endocannabinoid production in neuron2. At those mPFC
synapses that are exposed to high glucocorticoid concentrations and that are simul-
taneously stimulated by a homotypic stressor, the DSI switches are most likely to
be  turned into the ON position. Tagged in this way, theses synapses are prone to
undergo plastic changes through the induction of inhibitory long-term depression
(
n
d
‘
s
i
p
2
(
p
a
‘
2
p
u
g
e
2
a
i
t
w
e
2
5
t
s
m
w
i
a
e
i
r
vI-LTD) on neuron1 (Hill et al., 2011b). In such a case of synaptic plasticity at PFC
euron1, the principal neurons2 may  effectively disrupt stressor-induced amyg-
ala signaling to the upper brain stem. Such DSI-mediated processes may  lead to
all-or-none’ reactions resulting either in stress habituation or not.
ignaling to the LC-NE system, thereby preventing the transition
nto the hypervigilant state. The endocannabinoid system in the
refrontal cortex plays an important role in that process (Hill et al.,
010, 2011b). The endocannabinoids act in a bisynaptic process
Hill et al., 2011b) that is referred to as ‘depolarization-induced sup-
ression of inhibition’ (DSI) (Pitler and Alger, 1992). DSI functions
s a synaptic switch, and this is reason enough why  we observe
all-or-none’ reactions in stress habituation (Fig. 3) (Angeli et al.,
004).
The mechanistic elements involved in the DSI-switch are
romising candidates, which might allow discriminating habit-
ators from non-habituators. Among these candidates are the
lucocorticoid receptors (Malcher-Lopes et al., 2008; McKlveen
t al., 2013), the cannabinoid receptors (Fride et al., 2005; Hill et al.,
011a), and the endocannabinoid degrading enzyme fatty acid
mide hydrolase (Hill et al., 2013). Interestingly, polymorphisms
n the glucocorticoid and endocannabinoid receptor gene and in
he fatty acid amide hydrolase gene have been found associated
ith several differences in body shape and body mass (Benzinou
t al., 2008; van Rossum and Lamberts, 2004; Harismendy et al.,
010; Frost et al., 2010).
.2. Cardiovascular protection
In case of habituation to a homotypic stressor, the mPFC disrupts
he stressor-induced amygdala signaling not only to the LC-NE
ystem, but also to the hypothalamus. Here, particularly the ventro-
edial hypothalamus and the paraventricular nucleus are affected,
hich results in blunted SNS and HPA axis responses. Without rise
n SNS and HPA axis activity, the occurrence of high-ﬂow-speed
rterial turbulences becomes less likely (Falsetti et al., 1983; Hanai
t al., 1991). As already mentioned, evidence from cohort stud-
es shows that in people suffering from chronic stress, high stress
eactivity is positively associated with atherogenesis and cardio-
ascular mortality (Seldenrijk et al., 2012; Hamer et al., 2012; Lynchbehavioral Reviews 56 (2015) 139–150 145
et al., 1998; Everson et al., 1997; Carroll et al., 2012). The other way
round, people who  are low reactive to stress have a low risk of car-
diovascular mortality, even if they live in an unsafe environment. In
this way, habituators can turn off their network of allostasis when
being confronted with homotypic stressors. As a consequence of
alleviated allostatic load, habituators do not only accumulate less
visceral fat (Epel et al., 2000; Steptoe and Wardle, 2005; Goldbacher
et al., 2005), but are also protected against cardio- and cerebrovas-
cular disease (Seldenrijk et al., 2012; Hamer et al., 2012; Lynch et al.,
1998; Everson et al., 1997; Carroll et al., 2012).
5.3. Body mass gain
Blunted SNS and HPA-axis responses, however, put the indi-
vidual into a metabolic dilemma. Proper functioning of SNS and
HPA-axis is indispensable for maintaining cerebral functioning
and cerebral energy concentrations when food availability is low
(Klement et al., 2010; Peters and Langemann, 2009). When food
availability is high, however, a limited SNS and HPA axis effectiv-
ity can be compensated for by an increased body-pull (Klement
et al., 2010; Peters and Langemann, 2009). In detail: With blunted
brain-pull reactivity, the ‘percentage-of-glucose-allocated-to-the
brain’ decreases. Without taking countermeasures, the brain is at
risk of being undersupplied. Signiﬁcant for the context examined
here is the following simple relationship. The ‘percentage-of-
glucose-allocated-to-the brain’ multiplied by the ‘total energy
intake’ determines the ‘cerebral energy supply’. Thus, given
a decreased ‘percentage-of-glucose-allocated-to-the brain’, com-
pensatory enhancement of the ‘total energy intake’ enables the
brain to supply itself in an adequate manner. In such a situation,
subjects who restrain from ingesting the required extra energy
would suffer from two serious problems: ﬁrstly, ‘cerebral energy
sparing’ leading to neuroglycopenic states and low cognitive per-
formance (Brunstrom et al., 2005; Green et al., 2000; Kemps et al.,
2005; Kemps and Tiggemann, 2005) or, secondly, a ‘too high load
on the cerebral energy demand’ (indicated by high cortisol concen-
trations) (Rutters et al., 2009; Anderson et al., 2002; Rideout et al.,
2006; Tomiyama et al., 2010; Langfort et al., 1996; Edelstein et al.,
1983; Prouteau et al., 2006) leading to a reduction in bone mass
(Villareal et al., 2006; Vescovi et al., 2008) and menstrual irregu-
larities (Vescovi et al., 2008). Thus, habituators may  beneﬁt from
eating extra calories, namely from those that are needed in the
brain.
Again, there is a trade-off. As has been shown analytically, an
important property is inherent to the cerebral supply chain: The
‘percentage-of-glucose-allocated-to-the body’ increases in inverse
proportion to the ‘brain-pull reactivity’ (Peters and Langemann,
2009). Thus, in case of low brain-pull reactivity, the surplus of the
ingested energy is preferentially allocated to the body periphery
(Peters and Langemann, 2009). As the power of ‘cerebral insulin
suppression’ subsides, a particularly large amount of energy enters
the subcutaneous fat stores—thereby leading to body mass gain in
the long term.
Hence, habituators may  also experience the complications
of high body mass, which mainly include poor mobility and
osteoarthritis in knees and hips (Lohmander et al., 2009; Mork
et al., 2012; Wills et al., 2012). It should not be forgotten that
people with high body mass also suffer from weight stigmatiza-
tion that is quite common in our society (Puhl and Heuer, 2009;
Sikorski et al., 2012). But, on the other hand, habituators are
unlikely to build up visceral fat depots, because their cortisol con-
centrations are rather low (Epel et al., 2000; Steptoe and Wardle,
2005; Goldbacher et al., 2005). In this way, habituators who live in
uncertainty are likely sooner or later to develop a corpulent phe-
notype with predominant accumulation of subcutaneous fat (the
‘corpulent-but-narrow-waisted’ phenotype).
1 nd Biobehavioral Reviews 56 (2015) 139–150
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Fig. 4. Phenotypic diversity originating from heterotypic stressors prevailing in differ-
ent  stressful environments. Different phenotypic traits may develop when living in
stressful environments like the neighborhood, work, and home. Whether habitu-46 A. Peters, B.S. McEwen / Neuroscience a
Several lines of evidence support the hypothesis that low stress
eactivity is strongly linked to body mass gain. Epidemiological evi-
ence demonstrates that individuals with low stress reactivity are
t risk of gaining body mass over the next decades (Flaa et al., 2008;
hillips et al., 2012; Carroll et al., 2008). Experimental evidence
hows that corpulent subjects react to a mental and psychosocial
tress test in a low reactive manner (Jones et al., 2012; Kubera et al.,
012). When compared to lean subjects, the subjects with a high
ody mass displayed low cortisol reactivity to both an acute men-
al challenge and to a subsequent meal, displayed smaller changes
n the vigilant state, less pronounced post-stress-neuroglycopenic
tates, less pronounced rises in serum ketone concentrations, and
howed less ‘cerebral insulin suppression’ during a meal (Jones
t al., 2012; Kubera et al., 2012, 2014). Moreover, the corpu-
ent subjects showed less anxiety, less uneasiness, less physical
alaise and less sadness during the psychosocial challenge (Peters
t al., 2013). Thus, individuals with a high body mass demon-
trated low neuroendocrine, cardiovascular, neuroenergetic, and
motional reactivity to stress. There is further experimental evi-
ence showing that people with a high stress exposure, who were
ow reactive to a psychosocial challenge, consumed more calories
egardless whether they were stressed or not (Tryon et al., 2013).
ere we ﬁnd exactly determined what Dallman et al. (2003) has
ointed out more than 10 years ago: namely, reduced activity in
he chronic stress-response network and eating ‘comfort food’ go
ogether. In all, body mass gain can be regarded as an adverse effect
f habituators’ neuroenergetic strategy that safeguards cerebral
unctioning and cerebral energy concentrations.
. Non-homogeneous populations
When analyzing data from non-homogeneous populations, sci-
ntists often run into problems (Patterson et al., 2006). An example
hould illustrate this: A drug is tested in a placebo-controlled trial.
n the study sample, half of the subjects have a genetic factor that
s absent in the other half. The drug is effective only in combina-
ion with the genetic factor—otherwise it is harmful. At this point,
tatistical analysis fails to reveal signiﬁcant differences between
he drug- and the placebo-group. The pitfall of analyzing such a
on-homogeneous population is that the drug is classiﬁed as totally
neffective, although it actually has beneﬁcial effects in about half
f the cases.
With respect to body mass gain and loss, another thought pro-
oking set of paradoxical ﬁndings emerged. We  consider it closely
elated to the ‘obesity paradox’. First-year students at the Univer-
ity College of London reported an effect of perceived stress on
heir eating behavior and body mass: in particular, 42% reported
ecreased food intake, whereas 38% reported increased food intake
Oliver and Wardle, 1999). Later investigations of this university
tudent population revealed reported body mass gain in 55%, body
ass loss in 12% of the students, and stable body mass over the
ne-year period in 33% (Serlachius et al., 2007). Conﬁrmation came
rom larger cohort studies showing that some stressed individuals
ained body mass while others lost it (Kivimaki et al., 2006; Block
t al., 2009; Lopez-Jimenez et al., 2008). Given the evidence from
he above-mentioned ‘classical habituation experiment’ showing
hat two third of participants were habituators while one third
ere non-habituators (Kirschbaum et al., 1995), it is likely that
he London ﬁrst-year students also belong to a non-homogeneous
tudy population. To avoid false conclusions when analyzing stud-
es on body mass and body shape we should be aware of eventually
ealing with non-homogeneous study populations.
Complex environments acting on non-homogeneous popula-
ions produce a particularly high degree of phenotypic diversity.
ith habituation to a ‘homotypic’ stressor, the capability toation does occur or not depends on whether the situation-speciﬁc stress-induced
cortisol surge stimulates endocannabinoid production strongly enough to exceed
the critical threshold for the all-or-none habituation process.
respond to a novel ‘heterotypic’ stressor is still preserved. Thus,
habituation is likely related to recognizing that the same threat is
tolerable, but does not mean lack of vigilance to novel threats—an
important distinction, because habituation also means greater dis-
crimination and more precise responses, rather than a general
reaction to many stimuli, which is characteristic of an anxiety
disorder such as post-traumatic stress disorder and generalized
anxiety disorder. With heterotypic stressors originating from dif-
ferent stressful environments (e.g. work, home, or neighborhood)
diversity in phenotypes can develop (Fig. 4). It could be that a per-
son, who  habituated to the homotypic stressors at work, did not
habituate to heterotypic stressors prevailing at home, because the
response to the latter stressor does not exceed a certain thresh-
old. In this way, mixed phenotypes may  develop that exhibit
both subcutaneous and visceral fat accumulation. In all, non-
homogeneous populations living in complex environments may
generate a remarkable diversity of phenotypes.
Evolutionary biology has extensively studied adaptations to
environmental changes. When environments within the range of
a species differ, it is unlikely that any single phenotype will con-
fer high ﬁtness in all situations. In such a case, a change in the
phenotype (e.g., habituation, body shape) that depends on the envi-
ronment can provide increased environmental tolerance (Via and
Lande, 1985; Via et al., 1995; Agrawal, 2001).
7. Conclusions
For us as authors, it is the historical merit of Per Björntorp to
have laid the foundations for understanding how stress mediators
damage the cardiovascular system, how habituation protects the
vasculature, and why, in that context, the different fat distribu-
tion patterns – visceral vs. subcutaneous fat accumulation – display
diverging prognostic values.
When people live in unsafe environments their phenotype may
change during the life course. Broadly speaking, we  encounter three
human phenotypes (apart from mixed types): First, the phenotype
of people who  do experience ‘good’ stress only. They live in favor-
able socioeconomic environments and favorable emotional family
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nvironments. They experience challenge and reward, a sense of
astery and good self-esteem. Their body waist, hip and height
easurements stay well proportioned, and their cardiovascular
ortality risk remains low (Pulkki-Raback et al., 2015). Second, the
henotype of people who experience tolerable stress. Their cardio-
ascular mortality risk remains low, too (Seldenrijk et al., 2012;
amer et al., 2012; Lynch et al., 1998; Everson et al., 1997; Carroll
t al., 2012; Hamer and Stamatakis, 2012; Cameron et al., 2012;
erentzen et al., 2010; Petursson et al., 2011). They may  habituate
nd in so doing become able to tolerate aversive circumstances by
uffering the allostatic load. Their main trade-off is that they often
ecome corpulent (Flaa et al., 2008; Phillips et al., 2012; Carroll
t al., 2008) (thereby suffering mainly from osteoarthritis and poor
obility), but they do not accumulate much visceral fat (Epel et al.,
000; Steptoe and Wardle, 2005; Goldbacher et al., 2005). Third,
he phenotype of people who experience the unbuffered allostatic
verload of toxic stress. They belong to the non-habituators and
isplay compromised recovery. They become lean, but in spite of
hat they acquire large visceral fat depots (Epel et al., 2000; Steptoe
nd Wardle, 2005; Goldbacher et al., 2005). When compared with
abituators, they view themselves as having less self-esteem, and
eing more often in a depressed mood (Kirschbaum et al., 1995).
heir life-long risk for physical and mental disorders is increased
Xu et al., 2015). From among all of these phenotypes, they carry
he highest cardiovascular mortality risk (Seldenrijk et al., 2012;
amer et al., 2012; Lynch et al., 1998; Everson et al., 1997; Carroll
t al., 2012; Hamer and Stamatakis, 2012; Cameron et al., 2012;
erentzen et al., 2010; Petursson et al., 2011).
Based on the lessons learned from the modern population-based
tudies, which made combined use of waist circumference and
ody mass index, a simple and practical tool had been proposed
o assess the mortality hazard. It is called ‘Body Shape Index’ (ABSI)
nd describes the risk associated with visceral fat accumulation as
ndicated by a wide waist relative to body mass index and height
Krakauer and Krakauer, 2012, 2014). It predicted quite precisely
he mortality risks in the United States National Health and Nutri-
ion Examination Survey and in the British Health and Lifestyle
urvey. ABSI values are low in the ‘well-proportioned’ phenotype,
omparably low in the ‘corpulent-but-narrow-waisted’ phenotype,
nd high in the ‘lean-but-wide-waisted’ phenotype. With the help
f the ‘body shape index’ we can identify those lean high-risk peo-
le that have escaped medical attention for so long.
Based on evidence from randomized controlled trials, we here
ecommend paying more attention to this high-risk ‘lean-but-
ide-waisted’ phenotype and intervene against cardiovascular
isease and visceral fat accumulation by targeting their common
undamental cause (Kaufman et al., 2007; Orth-Gomer et al., 2009;
ulliksson et al., 2011). Such a more in-depth approach would
nvolve improving people’s psychosocial skills to cope with an
nhospitable environment (Storch et al., 2007; Hammerfald et al.,
006; Gaab et al., 2003; Orth-Gomer et al., 2009; Gulliksson et al.,
011) or, better still, improving people’s environment and provid-
ng them with more certainty (Ludwig et al., 2011, 2012).
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